Overview

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a pilot/feasibility study designed to investigate the feasibility of treating children with Ataxia-Telangiectasia (A-T) and cancer with regimens nearly as intense as non-A-T patients with cancer would receive.
Phase:
N/A
Details
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborators:
Children's Hospital of Philadelphia
National Cancer Institute (NCI)
Treatments:
6-Mercaptopurine
Asparaginase
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Etoposide
Mercaptopurine
Methotrexate
Prednisone
Procarbazine
Vinblastine
Vincristine